IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i4p2268-d751365.html
   My bibliography  Save this article

Androgen Deprivation Therapy for Prostate Cancer Did Not Increase the Risk of Retinal Vascular Occlusion: A Population-Based Cohort Study

Author

Listed:
  • Hsin-Le Lin

    (Department of Ophthalmology, Taipei City Hospital, Renai Branch, Taipei 106243, Taiwan
    These authors contributed equally to this work.)

  • Chia-Yi Lee

    (Department of Ophthalmology, Nobel Eye Institute, Taipei 106074, Taiwan
    These authors contributed equally to this work.)

  • Jing-Yang Huang

    (Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402367, Taiwan)

  • Po-Chen Tseng

    (Department of Ophthalmology, Taipei City Hospital, Renai Branch, Taipei 106243, Taiwan
    Department of Special Education, University of Taipei, Taipei 100234, Taiwan
    Department of Optometry, University of Kang-Ning, Taipei 114311, Taiwan)

  • Shun-Fa Yang

    (Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402367, Taiwan
    Institute of Medicine, Chung Shan Medical University, Taichung 402367, Taiwan)

Abstract

This study aimed to evaluate the effect of androgen deprivation therapy (ADT) on retinal vascular occlusion (RVO) development in patients with prostate cancer, using data from Taiwan’s National Health Insurance Research Database. A total of 1791, 1791, and 3582 patients were enrolled in the prostate cancer with ADT group, prostate cancer without ADT group, and the control group, respectively. The primary outcome was RVO occurrence, according to diagnostic codes. Cox proportional hazard regression was used to determine the adjusted hazard ratio (aHR) and 95% confidence interval (CI) of ADT and other covariates for RVO incidence. After a follow-up interval of up to 18 years, the patients with prostate cancer who received ADT showed significantly lower RVO incidence than the control group (aHR: 0.191, 95% CI: 0.059–0.621, p = 0.0059), after adjusting for multiple confounders. Hypertension was related to higher RVO incidence (aHR: 2.130, 95% CI: 1.127–4.027, p = 0.0199). Our overall results showed that using ADT for prostate cancer did not lead to a greater risk of RVO development. In fact, the patients with prostate cancer who received ADT had lower RVO incidence than those who did not receive ADT.

Suggested Citation

  • Hsin-Le Lin & Chia-Yi Lee & Jing-Yang Huang & Po-Chen Tseng & Shun-Fa Yang, 2022. "Androgen Deprivation Therapy for Prostate Cancer Did Not Increase the Risk of Retinal Vascular Occlusion: A Population-Based Cohort Study," IJERPH, MDPI, vol. 19(4), pages 1-10, February.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:4:p:2268-:d:751365
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/4/2268/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/4/2268/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Howard Hao Lee & Chang-Ching Yeh & Szu-Ting Yang & Chia-Hao Liu & Yi-Jen Chen & Peng-Hui Wang, 2022. "Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective: A Survey of Taiwanese Obstetric Specialists," IJERPH, MDPI, vol. 19(7), pages 1-15, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:4:p:2268-:d:751365. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.